Crunching the numbers. Responsibly.
Reliability concern: This paper was retracted on 2014-12-18. See notice: 10.1016/j.molcel.2014.11.029.
Strengths
Reciprocal co-immunoprecipitation, immunofluorescence, density-gradient fractionation, metabolic labeling, and siRNA knockdown all point to the same conclusion that SEL1L and LC3-I mediate selective clearance of EDEM1 and OS-9.
↳ Experimental Procedures; Figures 1-6
Swapping the cytosolic tails of SEL1L and CNX (SEL1LCNX and CNXSEL1L) localizes LC3-I binding and vesicular rerouting to SEL1L's cytosolic tail, providing domain-level resolution with a built-in specificity control.
↳ Figure 3B, 3D-3F
EDEM1 silencing had no effect on MHV replication while SEL1L and LC3 silencing did, a null outcome that is reported and discussed rather than omitted.
↳ Figure 6I; Results
Limitations
A RETRACTED watermark appears on every page of the full text. The specific grounds are not reproduced here, but the retraction is a material reliability signal that governs how the findings should be trusted and caps the displayed Craft score.
↳ Full text, pp. 809-819
Causal claims rest substantially on colocalization and co-immunoprecipitation; re-expression after knockdown or in vitro reconstitution would more directly demonstrate the proposed mechanism.
↳ Results; Experimental Procedures
Findings derive from HeLa and HEK293 cells and MHV with a modest 2-fold replication effect and no in vivo validation, leaving generalizability unaddressed.
↳ Figure 6I; Experimental Procedures
Withdrawn — shown for reference only
The assessment turns on two separable judgments: the science as presented and the article's reliability. On the merits, the design is competently executed, with multiple orthogonal assays converging on a specific mechanistic claim and a chimeric domain-swap that cleanly localizes LC3-I binding to SEL1L's cytosolic tail. Against this, key causal steps rely on colocalization and co-immunoprecipitation rather than reconstitution, colocalization quantifications omit cell counts (Figures 3G, 5H), and the work is confined to two cell lines with a modest 2-fold viral effect (Figure 6I). The decisive factor is the RETRACTED watermark present throughout the text, which sets the reliability flag to Red and caps the displayed Methodological Rigour score at 2.0 regardless of merit. Readers should treat the findings as unreliable pending review of the retraction notice, even though the internal argument as written is coherent.
Limited2.9/5.0
The paper identifies SEL1L as the previously elusive ERAD tuning receptor, maps LC3-I binding to its cytosolic tail, and proposes an autocrine, UPR-independent mechanism by which misfolded proteins enhance ERAD, extending the picture to coronavirus hijacking. The advance is specific and well-positioned against competing models, though several mechanistic steps remain inferential rather than directly demonstrated.
we identify the complex comprising the type-I transmembrane protein SEL1L and the cytosolic protein LC3-I as an ERAD tuning receptor
The design is competently executed, with reciprocal co-immunoprecipitation, confocal colocalization, isopycnic density-gradient fractionation, metabolic labeling, siRNA knockdown, chimeric-protein domain mapping, and a quantitative luciferase viral-replication assay converging on the same conclusions, supporting a merit-based score of 4.0; gaps include no reconstitution/rescue and colocalization quantifications without stated cell counts. The editorial Methodological Rigour score is capped at 2.0 due to the Red reliability flag arising from the RETRACTED watermark present throughout the text.
RETRACTED
The argument flows logically from the unidentified-receptor problem through orthogonal evidence to a summarizing model figure, with inferential claims generally hedged appropriately. Minor overstatement appears where correlational co-immunoprecipitation is described as having 'proved' complex formation.
This proved the presence of complexes between endogenous EDEM1 and SEL1L
The paper engages substantively with prior ERAD, autophagy, and coronavirus literature and explicitly positions itself against the competing mannose-timer and docking models. Limitations handling is underdeveloped, with no dedicated limitations paragraph and no discussion of siRNA off-target effects or cell-type generalizability.
challenge the "mannose timer model" of protein quality control and to propose an alternative "docking model"
Concerns4 of 4 checks
The paper's internal logic is consistent across summary, results, and discussion, with multiple orthogonal assays converging on the same conclusions and a reported null result (EDEM1 silencing has no effect on MHV replication) that argues against selective reporting. However, the document carries a RETRACTED watermark throughout, raising the possibility that data integrity issues identified post-publication bear on internal coherence.
The paper is explicitly marked RETRACTED throughout the supplied text. While no declared ethics problem, undisclosed conflict, or unverifiable data/code claim is independently visible in the text, a retracted paper must be treated as carrying at least one conduct-level concern that could change interpretation of core findings. No conflict-of-interest statement is present.
Flags: 0 declared / 5 total
All 50 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.
This paper was retracted on 2014-12-18. See notice: 10.1016/j.molcel.2014.11.029.
Sources: Retraction Watch ✓PubPeer (coming soon)
Low2.7/5.0
The work addresses a recognized problem area in ER proteostasis and coronavirus biology with identifiable research communities, but connects to decision-makers only generally and names no specific clinical or translational application. The disease links are framed as illustrative examples.
loss-of-function phenotypes reported for rheumatoid arthritis
Findings are early-stage mechanism characterization under controlled cell-culture conditions, far upstream of therapeutic or diagnostic use. The 2-fold reduction in MHV replication upon SEL1L silencing is a proof-of-concept observation rather than a deployable strategy.
silencing of SEL1L caused a 2-fold inhibition of MHV replication
Evidence rests on two human cell lines (HeLa, HEK293) and MHV, with no in vivo validation and no systematic exploration of boundary conditions or other cell types and pathogens. Generalizability remains unestablished.
HeLa cells were grown in MEM Alpha
The paper builds on an established line of work and provides a molecular handle (SEL1L) that subsequent studies could extend within the ERAD and host-virus literature. Its capacity to serve as a reliable cumulative foundation is materially compromised by the retraction.
remain matter for future studies
Lower confidence on Generalizability — domain match limited.
Nabu’s assessment, alongside the field’s view.
Evaluation Metadata
AI-powered, human-governed. Something look off? Contact us to request a review.